Dome Eventhall

With its innovative architecture and its 3000 m² of event space, Dome Eventhall is the number 1 event venue in Belgium. Strategically located, the venue is directly connected with central Brussels and Brussels airport with easy access from rest of Belgium, the Netherlands, France and Germany through Ringroad 21. An underground public parking of 1700 places is also available on site with direct access to the venue. Inside the Dome Uyou will find modern welcome facilities and a flexible 957 m² event space that are divided in 3 zones. It is equipped with a state-of-the-art technical kit including sound, light and video.

  • A 15' drive to/from the airport through N1 highway

  • Ideally located right by the junction of N1 and R21, the Dome provides easy access by car from all western Europe. An underground public parking of 1700 places is also available on site with direct access to the venue

  • Easy access by S-train from central Brussels. 8' ride from Brussel-Centraal to Schaerbeek station next to the venue

dome2.jpg
dome4.jpg
dome.jpg

Hotels

Brussels

Brussels, the capital of Belgium heart of Europe, is strategically located halfway between France and Germany. Just a short drive from the Netherlands, western Germany and northern France, Brussels provides easy access to the half of EU’s population to it either by car or public. transportation. Moreover, its airport is well connected to the rest of the continent and North America.

As the capital of Europe, the city gives businesses access to key European decision makers and opinion leaders.

Biotech in Belgium is a thriving industry at the forefront of innovation in life sciences, pharmaceuticals, medtech, healthcare, and more. 7% of Europe's biotech companies are based in Belgium., accounting for 16% of the continent's entire turnover and almost 10% of its R&D expenditure also marking a remarkable 28% increase in patent applications, signalling the sector's robust growth for the third consecutive year.

Belgium remains a frontrunner in the European biotech landscape, with only Germany and Denmark ahead.